NeoCodex logo — company profile

NeoCodex

Founded 2002 Series Unknown Total: $645.00K Biotechnology, Health Care

General Information

Company Name NeoCodex
Founded Year 2002
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when NeoCodex moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NeoCodex

NeoCodex is a biotechnology and healthcare startup founded in 2002, which delves into the genetic origins of diseases. The company's pioneering whole genome association study (WGAS) technology, along with genomic services and biomaterials, facilitates a profound understanding of human genetics and genetic variability. In March 2006, NeoCodex received a significant €645.00K Venture Round investment from Invercaria, enhancing its capabilities in discovering more precise pathways for developing future medicines. This investment reflects the growing interest in the potential of NeoCodex's approach to revolutionize the biotechnology and healthcare sectors.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1 •••• •••• 29 Mar 2006

NeoCodex Alternatives & Competitors

NeoCodex vs

Advancing genetic insights to shape a healthier future through comprehensive genomic analysis.

Biotechnology, Health Care
NeoCodex vs

We are reinventing the way people around the world access genetic expertise. Clear Genetic is deve...

Series Unknown
1 employees
Biotechnology, Health Care
NeoCodex vs

Genomics, Digital Health, AI, SAAS

Seed
17 employees
Big Data, Health Care

FAQ About NeoCodex

NeoCodex offers a profound comprehension of the genetic origins of diseases. Utilizing their pioneering whole genome association study (WGAS) technology, along with genomic services and biomaterials, researchers are discovering more precise pathways to developing future medicines by enhancing the un...
NeoCodex was founded in 2002.
NeoCodex operates in the following industries: Biotechnology, Health Care.
NeoCodex has completed 1 funding round, raising a total of $645.00K. The latest funding stage is Series Unknown.
Top alternatives and competitors to NeoCodex include Gene Health, Clear Genetics (YC W17, acquired by Invitae), The Gene Box, Metis Genetics, LLC, VIAGEN Genetic Diseases Assesment Center. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NeoCodex and Gene Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NeoCodex and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes